{"database": "openregs", "table": "federal_register", "rows": [["2018-06253", "Product-Specific Guidance for Doxycycline Hyclate; Revised Draft Guidance for Industry; Availability", "Notice", "The Food and Drug Administration (FDA or Agency) is announcing the availability of a revised draft guidance for industry on generic doxycycline hyclate oral delayed-release tablets, entitled \"Product- Specific Guidance for Doxycycline Hyclate.\" The revised draft guidance, when finalized, will provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for doxycycline hyclate oral delayed-release tablets.", "2018-03-29", 2018, 3, "https://www.federalregister.gov/documents/2018/03/29/2018-06253/product-specific-guidance-for-doxycycline-hyclate-revised-draft-guidance-for-industry-availability", "https://www.govinfo.gov/content/pkg/FR-2018-03-29/pdf/2018-06253.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA or Agency) is announcing the availability of a revised draft guidance for industry on generic doxycycline hyclate oral delayed-release tablets, entitled \"Product- Specific Guidance for Doxycycline Hyclate.\" The...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2018-06253"], "units": {}, "query_ms": 5.760842934250832, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}